Comparative Effectiveness of Dapagliflozin Versus DPP-4 Inhibitors

计划入组 11,206 人 · 首次发布于 2020 年 3 月 11 日

Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy

计划入组 109 人 · 首次发布于 2014 年 1 月 6 日

Approaches To Therapy Escalation In T2D

首次发布于 2019 年 1 月 23 日

Saxagliptin(Kombiglyze, Komboglyze, Onglyza, Qtern, Qternmet)

C₁₈H₂₅N₃O₂ · Rx

Sitagliptin(Janumet, Januvia, Ristaben, Steglujan, Tesavel, Velmetia, Xelevia, Sitagliptin SUN, Sitagliptin Accord, Ristfor, Efficib, Sitagliptin / Metformin hydrochloride Mylan, Sitagliptin / Metformin hydrochloride Accord)

C₁₆H₁₅F₆N₅O · Rx

Linagliptin(Glyxambi, Jentadueto, Tradjenta, Trajenta, Trijardy)

C₂₅H₂₈N₈O₂ · Rx

DPP PHARMACEUTICALS PTY LTD

Australia

Xi'an No.4 Hospital

China

Guiyang No.4 People's Hospital

China

GLP-1 Receptor Agonists Linked to Fewer Diabetic Foot Ulcers but Higher Charcot Risk Than DPP-4 Inhibitors

SGLT2 Inhibitors Linked to Increased Red Blood Cell Counts But No Thrombotic Risk in Type 2 Diabetes Patients

SGLT-2 Inhibitors Linked to Reduced Dementia and Parkinson's Risk in Type 2 Diabetes Patients